Highland Global Allocation Fund filings document the governance and shareholder-voting record of a NYSE-listed closed-end fund. Definitive proxy statements cover annual meeting matters, trustee elections or classifications, board oversight, committee roles, and compensation arrangements for non-employee trustees.
Material-event reports provide updates on board composition and related governance actions. The filing record also identifies the fund's common shares, HGLB trading symbol, exchange listing, registrant status, and capital-structure disclosures relevant to a closed-end management investment company.
Highland Global Allocation Fund is asking shareholders to re-elect Dr. Bob Froehlich as a Class II Trustee at the 2026 annual meeting on June 16, 2026 in Dallas, Texas. He would serve a three-year term, ending at the 2029 annual meeting, if approved.
The Board, composed entirely of independent Trustees, unanimously recommends a vote FOR his re-election. Shareholders of record at the close of business on April 30, 2026, when 23,590,445 common shares were outstanding, are entitled to vote. A quorum requires 33 1/3% of eligible shares, and proxies can be submitted by internet, phone, or mail.
Highland Global Allocation Fund ownership disclosure: Raymond James & Associates reports beneficial ownership of 2,353,160.53 common shares, representing 10.1% of the fund's common shares as of 03/31/2026. The filing shows sole dispositive power for 2,353,160.53 shares and no voting power. The amendment is signed on 04/07/2026.
Highland Global Allocation Fund is updating its board structure and governance documents. After the passing of Class I Trustee Bryan A. Ward, the Board accepted the resignation of Dorri McWhorter and, effective January 16, 2026, immediately reappointed her as a Class I Trustee. She resumes all prior committee roles, including chairing the audit committee, and will be paid under the fund’s standard non‑employee trustee compensation program described in its May 7, 2025 proxy statement. The Board also approved a Second Amended and Restated Declaration of Trust and Third Amended and Restated Bylaws, effective January 27, 2026, which consolidate prior amendments and further refine provisions on forum selection, shareholder proposals and nominations, related information requirements, and shareholder meetings.
Highland Global Allocation Fund (HGLB) received an amended Schedule 13G from Raymond James & Associates reporting beneficial ownership of 2,250,833.43 shares of common stock, representing 9.7% of the class as of September 30, 2025.
The filer reports no voting power (sole: 0; shared: 0) and sole dispositive power over 2,250,833.43 shares (shared: 0). Filed as an investment adviser (IA) under Rule 13d-1(b), the certification states the holdings were acquired and are held in the ordinary course and not to change or influence control.